Synopsis: Wockhardt Ltd shares rally 37% in the last two days after FDA approval of ZAYNICH™ for cUTI, which showed 89% cure vs 68.4% with meropenem in Phase 3 ENHANCE-1, with QIDP/Fast Track status and global filings underway. The shares of a Mid-Cap company...
Synopsis: Healthcare stock surged 12 percent after FY26 results, driven by strong biotech growth, emerging market expansion, margin improvement, and a turnaround in profitability to Rs 199 crore PAT. The share of this company, which focuses on pharmaceutical...
The shares of the pharmaceutical company specializing in the pharmaceutical and biotechnology sectors, focusing on the research, development, manufacturing, and marketing, are in focus as the stock has rallied upto 19 percent in the day’s trade. In this article, let’s...
Breakout stocks are those whose prices jump past important resistance levels on a chart, suggesting the start of a new uptrend. When a stock moves above a recent high or pattern boundary, it shows renewed buying strength and often draws investor interest due to its...
Following the results of the 2024 Lok Sabha elections, which saw Prime Minister Narendra Modi secure a historic third term, the Indian stock market experienced sharp movements as investors reacted to the political outcome. While initial volatility gripped the markets,...
During Monday’s trading session, the shares of a research-based Global Pharmaceutical and Biotech company surged nearly 4 percent to Rs. 1,441.95, after its antibiotic drug ‘Zaynich’ achieved 97 percent effectiveness in treating severe pneumonia infections. With...
Pharma stock engaged in manufacturing injectables, finished dosage formulations, orals, biopharmaceuticals, and topicals jumped up to 4 percent in the day’s trade following the press release from the company that filed insulin injection for DCGI’s approval. ...
